Other headlinesVital Images shuffles exec ranksNightHawk buys founder's shares
Philips enhances xcelera with 'tele-cardiology'
Philips has added a tele-cardiology capability to its multimodality Xcelera product. The informatics technology, Xcelera R3.1, builds remote access to cardiac information into its cardiology image management, analysis and reporting. The tele-cardiology function supports image sharing with referring physicians, as well as access to Xcelera capabilities through other information systems, such as an electronic health records system. Xcelera R3.1 is currently operating at Harborview Medical Center, part of University of Washington Medicine.
Vital Images shuffles exec ranks
Advanced visualization specialist Vital Images has named Erkan Akyuz as its new executive vice president of engineering. Vikram Simha relinquishes the executive VP slot but will continue as chief technology officer, setting direction and vision for the company's enterprise platform, as well as expanding relationships with marquee customers. Akyuz will be in charge of product development. He will report to president and CEO Michael H. Carrel.
NightHawk buys founder's shares
On Aug. 12, teleradiology firm NightHawk bought three million shares of its common stock from company founder and former chairman Dr. Paul E. Berger. The company paid $4.63 per share, reflecting a 6% discount from the closing price on the effective date of the purchase.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.